Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain
Brief Summary
Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.
Condition or Disease
- Pain, Postoperative
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 16 Years and older (Child, Adult, Older Adult) |
| Enrollment: | 40 () |
| Funded by: | Industry |
Masking |
|
Clinical Trial Dates
| Start date: | Mar 01, 2020 | |
|---|---|---|
| Primary Completion: | Apr 01, 2020 | |
| Completion Date: | Apr 01, 2020 | |
| Study First Posted: | Jun 20, 2007 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Feb 07, 2008 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 16 |
More Details
| NCT Number: | NCT00488787 |
|---|---|
| Other IDs: | KET-003 |
| Study URL: | https://ClinicalTrials.gov/show/NCT00488787 |
Last updated: Feb 22, 2021